$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000155335014001377 Filed on November 14, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$0.00	$9.740K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.130M	$830.0K	$740.0K
YoY Change	14.14%	12.16%	221.74%
% of Gross Profit
Research & Development	$440.0K	$1.025M	$992.4K
YoY Change	-29.03%	3.33%	309.69%
% of Gross Profit
Depreciation & Amortization	$30.00K	$22.95K	$1.229K
YoY Change	200.0%	1767.53%
% of Gross Profit
Operating Expenses	$3.700M	$3.116M	$1.961M
YoY Change	64.44%	58.92%	275.43%
Operating Profit		-$3.116M	-$1.961M
YoY Change		58.92%	277.68%
Interest Expense	-$50.00K	$8.138K	$40.64K
YoY Change	-266.67%	-79.97%	-167.73%
% of Operating Profit
Other Income/Expense, Net	$20.00K	-$11.16K	-$68.37K
YoY Change	-80.0%	-83.68%	11.15%
Pretax Income	-$3.730M	-$3.130M	-$2.030M
YoY Change	75.94%	54.19%	250.0%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.610M	-$3.000M	-$2.329M
YoY Change	75.24%	28.82%	310.19%
Net Earnings / Revenue		-30804.97%
Basic Earnings Per Share
Diluted Earnings Per Share	-$40.11	-$33.33	-$33.28
COMMON SHARES
Basic Shares Outstanding	6.482M shares	6.464M shares	6.366M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.40M	$15.40M	$23.60M
YoY Change	-34.25%	-34.75%	23500.0%
Cash & Equivalents	$3.714M	$3.282M	$23.58M
Short-Term Investments	$10.70M	$12.10M
Other Short-Term Assets	$900.0K	$600.0K	$800.0K
YoY Change	-18.18%	-25.0%	700.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$15.28M	$16.09M	$24.40M
YoY Change	-33.38%	-34.06%	12099.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$445.5K	$464.3K	$13.10K
YoY Change	728.85%	3444.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$194.1K	$183.5K	$0.00
YoY Change	446.55%		-100.0%
Total Long-Term Assets	$639.7K	$647.8K	$10.86K
YoY Change	616.53%	5863.94%	-89.14%
TOTAL ASSETS
Total Short-Term Assets	$15.28M	$16.09M	$24.40M
Total Long-Term Assets	$639.7K	$647.8K	$10.86K
Total Assets	$15.92M	$16.74M	$24.42M
YoY Change	-30.86%	-31.47%	8041.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.367M	$680.5K	$392.5K
YoY Change	109.75%	73.36%	-21.49%
Accrued Expenses	$806.0K	$446.2K	$157.3K
YoY Change	60.22%	183.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$100.0K	$0.00
YoY Change
Total Short-Term Liabilities	$2.571M	$1.257M	$572.0K
YoY Change	117.81%	119.72%	14.39%
LONG-TERM LIABILITIES
Long-Term Debt	$2.300M	$1.100M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities			$200.0K
YoY Change			100.0%
Total Long-Term Liabilities	$0.00	$0.00	$200.0K
YoY Change	-100.0%	-100.0%	-66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.571M	$1.257M	$572.0K
Total Long-Term Liabilities	$0.00	$0.00	$200.0K
Total Liabilities	$4.885M	$2.315M	$786.3K
YoY Change	274.93%	194.43%	-28.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.14M		-$10.29M
YoY Change
Common Stock	$982.00	$979.00	$959.00
YoY Change	2.19%	2.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.76M	$15.03M	$23.85M
YoY Change
Total Liabilities & Shareholders Equity	$15.92M	$16.74M	$24.42M
YoY Change	-30.86%	-31.47%	8041.09%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$3.610M	-$3.000M	-$2.329M
YoY Change	75.24%	28.82%	310.19%
Depreciation, Depletion And Amortization	$30.00K	$22.95K	$1.229K
YoY Change	200.0%	1767.53%
Cash From Operating Activities	-$2.480M	-$2.850M	-$2.880M
YoY Change	53.09%	-1.04%	405.26%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$0.00	$10.00K
YoY Change	-75.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$1.380M	-$1.290M
YoY Change	-107.95%
Cash From Investing Activities	$1.380M	-$1.290M	-$10.00K
YoY Change	-107.94%	12800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.540M	1.430M	23.44M
YoY Change	15300.0%	-93.9%	11061.9%
NET CHANGE
Cash From Operating Activities	-2.480M	-2.850M	-2.880M
Cash From Investing Activities	1.380M	-1.290M	-10.00K
Cash From Financing Activities	1.540M	1.430M	23.44M
Net Change In Cash	440.0K	-2.710M	20.55M
YoY Change	-102.32%	-113.19%	-5808.33%
FREE CASH FLOW
Cash From Operating Activities	-$2.480M	-$2.850M	-$2.880M
Capital Expenditures	$10.00K	$0.00	$10.00K
Free Cash Flow	-$2.490M	-$2.850M	-$2.890M
YoY Change	50.0%	-1.38%	407.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	27000000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24300000	USD
CY2013Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1696683	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	36167	shares
	us-gaap	Depreciation Depreciation	41850	USD
	us-gaap	Depreciation Depreciation	2877	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14421504	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	515757	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63312	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51409	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9559	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53753	USD
CY2014Q3	us-gaap	Depreciation Depreciation	22952	USD
CY2013Q3	us-gaap	Depreciation Depreciation	1229	USD
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	190987	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	356588	USD
CY2014Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	35000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2014Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	41050	USD
CY2014Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	179125	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	106462	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	446162	USD
CY2013Q4	us-gaap	Accrued Rent Current AccruedRentCurrent		USD
	htbx	Cashless Exercise Of Stock Option CashlessExerciseOfStockOption		USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21717145	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	37719	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	452874	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	722358	USD
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2500000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25000000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22400000	USD
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.45
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	20549	shares
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	122590	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	7263	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	-452874	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67794	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	44106	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.19
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	836961	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.082	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0215	pure
CY2014Q3	us-gaap	Share Based Compensation ShareBasedCompensation	224586	USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25110000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	725000	USD
	htbx	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Value At Issuance FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityValueAtIssuance	323021	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	633482	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	315379	shares
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	26793	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	722358	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	377388	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	440615	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.29
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	440615	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.29
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2964247	USD
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	261371	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P14M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28229	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23573415	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5030	USD
	htbx	Amortization On Bond Premium AmortizationOnBondPremium	137897	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7263	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	122202	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	18446	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	10813	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-418275	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	742029	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-24672	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-10478	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	28561	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-112943	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-56888	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	28071	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	8387	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7349716	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4765827	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	13827773	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	8783623	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	452444	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4591706	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37719	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	942052	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1473002	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28344436	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1285008	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3281984	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23578445	USD
	us-gaap	Interest Paid InterestPaid	51575	USD
	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge	2300000	USD
	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable	197099	USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	452874	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	13848	USD
	htbx	Amortization On Bond Premium AmortizationOnBondPremium		USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	100000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments		USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5194	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	540	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5194	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
	us-gaap	Interest Paid InterestPaid	8138	USD
	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge		USD
	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable		USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants		USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1435283	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	197099	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	47957	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4313399	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock		USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock	386	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1025442	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	992360	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2425404	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2121628	USD
CY2014Q3	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1258566	USD
CY2013Q3	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	230924	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	3218137	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	747915	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	832101	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	737540	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2844883	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1443856	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	3116109	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	1960824	USD
	us-gaap	Operating Expenses OperatingExpenses	8488424	USD
	us-gaap	Operating Expenses OperatingExpenses	4313399	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3116109	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1960824	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8488424	USD
CY2014Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9740	USD
CY2013Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	500	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	27261	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	502	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12762	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-28229	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39291	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-78191	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	40639	USD
	us-gaap	Interest Expense InterestExpense	100780	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11160	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-68368	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20168	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-178469	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	-3127269	USD
CY2013Q3	us-gaap	Profit Loss ProfitLoss	-2029192	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-126865	USD
CY2013Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-61750	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-3000404	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-2329110	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6469272	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4835582	shares
CY2014Q3	us-gaap	Interest Expense InterestExpense	8138	USD
	us-gaap	Interest Expense InterestExpense	8138	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2014Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
CY2013Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	122590	USD
CY2014Q3	us-gaap	Liabilities Liabilities	2315156	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1302921	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6481752	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6375426	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	979	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	961	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35550524	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34337591	USD
CY2014Q3	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	20524547	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	648363	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1066638	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	16088857	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	22955741	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464348	USD
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	101252	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
CY2014Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19798	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	183455	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10572	USD
CY2014Q3	us-gaap	Assets Assets	16736660	USD
CY2013Q4	us-gaap	Assets Assets	23020066	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	680478	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	651917	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503050	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25364	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1256681	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180331	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	12346630	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	15026956	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	21991922	USD
CY2014Q3	us-gaap	Minority Interest MinorityInterest	-605452	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-274777	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16736660	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23020066	USD
CY2014Q3	us-gaap	Interest Payable Current InterestPayableCurrent		USD
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2014Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	12115118	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	17297165	USD
CY2014Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	43392	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	24946	USD
CY2014Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	62405	USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet		USD
CY2014Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	1058475	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2014Q3	us-gaap	Notes Payable Current NotesPayableCurrent	130041	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent		USD
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6481752	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6375426	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-330675	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-139796	USD
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Profit Loss ProfitLoss	-4491868	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Profit Loss ProfitLoss	-8508592	USD
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6481752	shares
	us-gaap	Net Income Loss NetIncomeLoss	-8177917	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7013740	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6445129	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2863310	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.27
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.45
CY2014Q3	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2013Q3	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2014Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
CY2013Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
CY2013Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4348	pure
	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30

Files In Submission

Name	View Source	Status
0001553350-14-001377-index-headers.html	Edgar Link	pending
0001553350-14-001377-index.html	Edgar Link	pending
0001553350-14-001377.txt	Edgar Link	pending
0001553350-14-001377-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20140930.xml	Edgar Link	completed
htbx-20140930.xsd	Edgar Link	pending
htbx-20140930_cal.xml	Edgar Link	unprocessable
htbx-20140930_def.xml	Edgar Link	unprocessable
htbx-20140930_lab.xml	Edgar Link	unprocessable
htbx-20140930_pre.xml	Edgar Link	unprocessable
htbx_10q.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2014 Q4 Form 10-Q Financial Statement

#000155335014001377 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2014 Q4 Form 10-Q Financial Statement

#000155335014001377 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx